Home
|
Press
|
Events
|
Eshare
Sign in
/
Register
0
Shopping Cart
X
Close
My Products (0 items)
My shopping cart is empty.
.
Sign in
/
Register
X
Close
Login/Register
Email
Password
INDUSTRIES
Agriculture
Chemicals
Food & Feed
Pesticides
Titanium Dioxide (TiO2)
Dairy Products
Full Industry List
ONLINE DATABASE
PRODUCTS & SERVICE
Products' Introduction
Industrial Reports
Newsletters
Market Data
Content Byte
Agrochemical Regulatory
Customized solutions
IMPACT FACTOR
MARKET NEWS
Agriculture
Chemicals
Food & Feed
Other
ABOUT
About CCM
Why CCM?
CCM Story
CCM Clients
Events
Career
Company news
CONTACT
Home
Product
Newsletters
>
丽珠医药募集14.2亿用于发展前景良好的医药产品项目
Read online
丽珠医药募集14.2亿用于发展前景良好的医药产品项目
摘要:由于相关产品国内市场发展潜力巨大,丽珠医药非公开发行股票募集14.2亿元用于艾普拉唑、单抗和长效微球缓释制剂的相关项目建设。目前丽珠医药营收和净利润实行双丰收,2016年上半年艾普拉唑肠溶片销售收入上涨70.19%,苯丙氨酸销售收入上涨27.19%2016年12月28日,丽珠医药集团股份有限公司(丽珠医药)发布公告,2016年9月20日在深交所非公开发行A股股票数量达到2909.82万股,发行价为每股人民币50.10元,募集资金总额约14.58亿,扣除发行费用后实际募集资金净额为14.2亿...
Amino Acids China E-News 201701(Chinese version)
Add to DIY report
Select whole article
I haven't create reports,
create a new report
right now!
Recommend Newsletters
Crop Farming in China
2016/05/31
More>>
Report on Glyphosate Business Opportunities Worldwide
2016/07/27
More>>
Specialised Control and Prevention of Pests and Diseases for Crops in China
2016/07/12
More>>
Loading...